Showing results (491-500 of 762) with videos related to
Sort By:
Pageof 77
Current Oncology (Toronto, Ont.)|March 27, 2024
ITGAV Promotes the Progression of Head and Neck Squamous Cell CarcinomaLingyi Xu, Jeremy G Barrett, Jiayi Peng, et al.Annals of Neurology|September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaJ Sian, D T Dexter, A J Lees, et al.Neuroscience Letters|October 12, 2001
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophyH R Morris, A Schrag, U Nath, et al.Neuroscience|May 1, 1995
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's diseaseA P Nisbet, O J Foster, A Kingsbury, et al.Lancet (London, England)|October 15, 1977
Deprenyl in Parkinson's diseaseA J Lees, K M Shaw, L J Kohout, et al.Annals of Neurology|July 1, 1991
Dopa-responsive dystonia: [18F]dopa positron emission tomographyG V Sawle, K L Leenders, D J Brooks, et al.Lancet (London, England)|September 8, 1990
Neurological deterioration in young adults with phenylketonuriaA J Thompson, I Smith, D Brenton, et al.Lancet (London, England)|December 24, 1988
Role of subcutaneous apomorphine in parkinsonian voiding dysfunctionT J Christmas, P A Kempster, C R Chapple, et al.Neuroscience|November 1, 1996
Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's diseaseA P Nisbet, D J Eve, A E Kingsbury, et al.Journal of Parkinson'S Disease|August 13, 2013
Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesiaH S Lindgren, D Rylander, H Iderberg, et al.Pageof 77